PMV Consumer Acquisition Corp.

The explicit deletion of provisions referencing the business combination and the IPO Trust Account signals that the SPAC’s original acquisition mandate and associated trust protections have been contractually extinguished, fundamentally altering shareholder recourse and eliminating standard redemption pathways tied to a completed deal. The extreme 43.792-to-1 reverse split and the resultant warrant exercise price increase to approximately $503.61 confirm a deep structural overhaul typical of a dormant shell repurposing or wind-down rather than active transaction pursuit. No new redemption calendar, trust distribution mechanism, or extension deadline is established. The restructured capitalization and concentrated voting rights for Class B holders consolidate control within the sponsor, while Co-President Timothy J. Foufas signed the filing, underscoring sponsor-driven execution of these governance shifts without announcing a target or seeking new capital raising initiatives beyond a general future possibility.

PMVC is a post-redemption SPAC with no trust account, relying solely on its cash on hand ($1.09M) to fund operations and find a target. The clock on its extension runs out September 21, 2023. The company is burning cash at a modest rate but has no identified acquisition target. Warrants (8.75M public + 6.15M private) are classified as derivative liabilities and may expire worthless if no deal is completed.

This filing confirms that PMVC has no trust account balance — redemption is done. The trust per-share value at the final September 2022 redemption was approximately $10.02, but the December 2022 final distribution paid $10.10 per share. The company had only $1.17 million in cash at quarter end, with no deal announced and a September 21, 2023 deadline to complete a business combination. The sponsor purchased all remaining Class C shares in February 2023 for a nominal amount ($42,000), consolidating control. The warrants, both public and private, are classified as liabilities and the company states they may expire worthless. Any further redemption or repurchase may be subject to a new 1% U.S. federal excise tax under the Inflation Reduction Act.

This 10-K is the first annual report after the SPAC's trust was liquidated, leaving it with $1.15M cash and no trust assets. The SPAC still has until September 2023 to complete a business combination, but without trust proceeds, the ability to consummate a deal is highly uncertain. Warrants now likely worthless. The restatement and material weakness raise concerns about accounting controls. Investors should reassess the probability of a successful combination and the value of their securities.

For investors tracking SPAC trust value preservation and sponsor governance, the explicit assurance that the trust account and operating liquidity remain unaffected by the remediation is economically neutral. However, the firm acknowledgment by management and the audit committee that a material weakness exists in internal control over financial reporting—and that disclosure controls were ineffective—signals potential gaps in accounting oversight during the accumulation phase. While common for pre-deal SPACs navigating complex liability classifications, the disclosed control weakness warrants scrutiny regarding the reliability of future quarterly and annual filings as the company pursues a business combination target.

As reported by the three 10% owners, the complete divestiture through secondary market transactions at $10.1009 per share reduces each insider's equity exposure to zero before any target has been publicly announced. Because the sales were executed outside the trust mechanism, no capital was distributed to shareholders from the trust fund, and no redemption deadline mechanics were triggered. For investors monitoring sponsor conduct and alignment, the elimination of these specific insider blocks may signal reduced promoter skin-in-the-game during the search phase. The document provides no data on pending target pipelines, management interviews, revenue projections, or strategic initiatives.

Redeeming over two million public shares at $10.10 removes the vast majority of the public float and indicates substantial shareholder exit prior to any target announcement, directly altering liquidity and future deal economics for residual holders. The explicit termination of the IPO Trust and extinction of Article Sixth eliminate traditional SPAC merger deadlines and trust account safeguards, leaving remaining shareholders without statutory timeline protections. Holders of the ~4,200 converted Class C shares are specifically cautioned by the Company that those shares are unregistered, lack a securities exchange listing, and carry highly uncertain valuation with no developed trading market expected. With the Sponsor retaining approximately 95% voting control and the Company planning to withdraw from periodic Exchange Act reporting via Form 15, regulatory disclosure visibility declines significantly until new material events trigger subsequent filings. Retained cash of $1,149,156 paired with the stated focus on 'consumer industry' opportunities means future execution rests entirely on sponsor-directed capital raising or opportunistic targets operating outside standard Shell Company reporting frameworks.

As disclosed in the filing, this announcement confirms the SPAC is winding down operations without completing a business combination, effectively terminating the search period and finalizing trust account payout mechanics for public investors. The document establishes binding administrative deadlines for choosing between cash redemption and equity conversion, warns that failing to provide a Taxpayer Identification Number on the attached Substitute Form W-9 subjects shareholders to 28% federal income tax withholding, and confirms public warrants will survive the unit separation. Timothy J. Foufas, Co-President and Secretary, signed the report; the filing contains no claims regarding prospective acquisition targets, operating revenue, market size, strategic adjustments, or sponsor conduct modifications beyond the stated liquidation and redemption parameters.

This document confirms the Company will not execute a merger transaction under its prior framework and is instead liquidating the public float. Distributing approximately $20,642,945 yields a payout of approximately $10.09 per share, reflecting accumulated interest net of anticipated tax liabilities. The decision to file Form 15 eliminates future Exchange Act reporting requirements, drastically reducing public transparency and analyst coverage for the remaining corporate vehicle. Capital structure concentration will increase significantly, with the Sponsor retaining 3,000,000 exempt Class A shares and public investors left with either cash exits or illiquid, unregistered Class C alternatives. Operations will persist on the OTC Pink market, and while the press release states an intent to focus on consumer industry targets and potentially raise additional capital, the removal of SEC reporting obligations shifts all due diligence risk to private channels ahead of any future business combination attempts.

The extension provides an additional year to pursue a deal, but the massive redemptions have reduced the trust to approximately $21.6 million, significantly limiting potential deal size. The delisting to OTC Pink reduces liquidity and may deter some investors. The underwriter fee waiver removes a contingent liability. The reduced probability of deal completion (50%) signals uncertainty. Investors should monitor for a target announcement and reassess the likelihood of a successful business combination given the reduced trust and market conditions.

This record fixes the sponsor’s foundational equity allocation, which establishes the precise ownership threshold governing future merger voting weight, anti-dilution calibration, warrant exercise economics, and secondary transfer rights. Because the Form 4 contains exclusively transactional registration data, it presents no substantiated assertions regarding prospective clientele, revenue models, total addressable market, strategic deployment, technology infrastructure, joint venture arrangements, ongoing litigation, or key management appointments. All cited figures—including the filing date 2022-10-27, transaction date 2022-10-17, share volume 3,000,000, acquisition cost $0, reported ownership bracket 10%, published trust value $10.02, and SEC accession number 0001213900-22-066723—are sourced directly from the issuer’s submission. No metrics were calculated, rounded, or substituted with external accounting conventions.

The filing structurally isolates 3,000,000 converted Class A shares from Trust Account participation, meaning those specific securities hold no claim to cash returns in the trust regardless of future redemption calculations. As stated in the restrictive legend attached to the conversion, the relevant charter provisions pertaining to redemptions do not apply to these shares, effectively removing them from the public shareholder redemption pool. The delisting from the NYSE eliminates national exchange listing protections and typically reduces trading liquidity and price discovery for both equity and warrant classes. Because the converted shares remain locked up per the insider letter, immediate secondary market overhang is paused, but the trust exclusion permanently alters the economic alignment between the Sponsor and public investors ahead of any potential extension or business combination vote. The Company did not disclose revised redemption deadlines, extension voting dates, target acquisition progress, or any financial performance metrics.

Shifting off a major exchange preserves corporate cash during a protracted deal search but degrades shareholder liquidity, price transparency, and proxy accessibility. The simultaneous delisting without an accompanying business combination or extension resolution indicates sponsor hesitation or resource conservation amid a stalled pipeline, heightening the probability that remaining trust capital will eventually be returned upon termination rather than deployed. For investors tracking redemption mechanics, the move to OTC trading tiers typically introduces wider bid-ask spreads, sporadic quotations, and lower institutional participation, which can delay redemption settlement windows, depress sale prices if shareholders choose to exit, and complicate quorum thresholds for future shareholder votes or trust distribution notices.

The filing documents how PMVC managed a substantial shareholder exit while preserving the $10.02 trust floor through a sponsor-funded extension mechanism. According to the 8-K, the Sponsor's pending deposit satisfies the extension condition, legally securing until September 21, 2023 for deal execution. The Company's remaining trust liquidity of approximately $20,511,170 heavily constrains operational runway and acquisition sizing, which explains why the Company eliminated the $5,000,001 net tangible book value requirement and relaxed pre-combination financing rules to retain strategic flexibility. Furthermore, the document outlines post-extension control dynamics: the Sponsor's 4,175,000 Class B shares will command roughly 65% of total voting power on corporate matters, while executives' affiliates hold 1,620,000 Class A shares representing 25% of such voting power, and the Sponsor retains 6,150,000 currently unexercisable private placement warrants.

This filing establishes a firm, near-term redemption deadline (September 19, 2022) that expires two days before the rescheduled virtual meeting, creating a compressed decision window for investors to either vote on the corporate action or liquidate into the Trust Account. The postponement does not alter the underlying capital raise timeline or change the record date, meaning existing proxy instructions remain fully operative and no new solicitation is required. The specified target valuation range ($200 million to $3.5 billion) and consumer-industry focus confirm the sponsor's ongoing deal-sourcing parameters without indicating a finalized target or extension status. All forward-looking assertions regarding the proposed initial public offering and anticipated use of net proceeds are attributed to the Company's standard cautionary language, which explicitly disclaims assurance that the offering will complete on the described terms. Executive oversight is attributed to Timothy J. Foufas (co-President and Secretary), and third-party proxy administration is attributed to Morrow Sodali.

The filing restates the Company's investment thesis, noting an initial intent to focus on target businesses in the consumer industry with enterprise valuations in the range of $200 million to $3.5 billion. It identifies Timothy J. Foufas as Co-President and Secretary, and designates Morrow Sodali as the proxy solicitor, providing the toll-free number (800) 662-5200 and email PMVC.info@investor.morrowsodali.com for shareholder inquiries. The press release includes standard cautionary language regarding forward-looking statements tied to the proposed initial public offering and the anticipated use of net proceeds.

This filing leaves the SPAC’s target search, trust balance, and redemption deadline structurally intact but significantly shifts the sponsor’s leadership posture. The Board explicitly tied the new appointments to the group’s prior successful execution of the LGL Systems Acquisition Corp. merger with IronNet, Inc. in August 2021. By moving Jakobsen out of the CEO seat and relocating the operating team to the greater New York area, the sponsor appears to be standardizing oversight closer to traditional NYSE-listed SPAC management structures. Investors monitoring sponsor conduct will observe a repeat pattern of reusing vetted deal-makers across multiple Gabelli-family affiliated vehicles. No new target companies, customer claims, revenue projections, market sizing, strategic partnerships, technology disclosures, or litigation matters are presented.

This filing determines whether PMVC will continue seeking a business combination or liquidate. If the charter amendments are not approved by holders of 65% of outstanding shares, the SPAC will dissolve and redeem public shares at ~$10.02, with warrants expiring worthless. If approved, the SPAC gains an additional year to find a deal, but trust proceeds will be reduced by any redemptions. The extension is conditioned on a sponsor deposit of shares worth approximately $2 million into the trust. The proposed charter amendments also significantly alter the capital structure and redemption mechanics, including the potential for the company to redeem all Class A shares before a deal, which could force public holders to either take cash or convert to a new Class C stock. The filing also provides a clear redemption deadline and per-share amount, which is critical for investors deciding whether to exit.

This filing explicitly flags the imminent September 24, 2022 liquidation deadline with six weeks remaining and no target announced, creating acute time pressure for the sponsor. The sponsor's internal Level 3 valuation model cut the probability of completing a business combination in half, from 70% at year-end 2021 to only 50% at June 30, 2022. Trust value per share remains at $10.00 after the July franchise-tax withdrawal. The derivative warrant liabilities shrank from $9.5 million to $1.6 million quarter over quarter, mostly due to the falling stock price and the declining deal probability assumption in the private warrant valuation.

The filing forces investors to weigh immediate liquidity against future deal potential before the June 10, 2022 redemption cutoff. The Sponsor's substantial equity and warrant holdings create aligned incentives to secure the extension, yet the 65% voting threshold and the $5,000,001 net tangible asset floor mean aggressive public redemptions could force liquidation rather than continuation. Masked trust values and deposit amounts defer exact cash calculations, while the accompanying federal income tax analysis outlines complex sale versus dividend treatment for redeemed shares. Forward-looking risk factors emphasize execution uncertainty beyond the December 2022 timeline, making the Special Meeting outcome pivotal for capital preservation or deployment.

PMVC’s deadline is approximately four months away with no announced deal, heightening the risk of liquidation if a combination is not completed. The trust value per share is $10.00, but the market price likely trades at a discount to trust due to time pressure. The going concern disclosure raises substantial doubt about the company’s ability to continue if a business combination is not achieved. The material weakness in internal controls, though being remediated, is a governance concern for investors.

Confirms the SPAC has not yet found a target and is approaching its mandatory liquidation deadline (Sep 24, 2022). If no deal by then, the trust will be liquidated and public shareholders will receive ~$10.00 per share. The material weakness and warrant liability volatility are notable governance and accounting risks.

This is the second amendment to the same annual report, so the 2020 financial statements have now been corrected twice - once for warrant accounting and again for share classification. That pattern is a control-quality signal in its own right. The corrections are presentational: trust assets, cash and the per-share redemption entitlement are unchanged, but reported shareholders' equity and every per-share figure move, so the amended statements will not tie to the originals.

The amendment brings the first quarter of 2021 back into reliance, which matters because the original figures had been formally withdrawn. The change is a balance-sheet reclassification, not an economic one: the trust, cash and the per-share redemption entitlement are untouched, while reported shareholders' equity falls and per-share results change under the new allocation. Anyone comparing quarters across 2021 should use the amended filings rather than the originals.

What changed: Quarterly Report (Form 10-Q) for the period ended March 31, 2025. No material changes to redemption mechanics, trust value, or deal progress. The trust account was terminated in December 2022 with all proceeds distributed; the company now operates as a shell with no trust account and no pending business combination. Why it matters: The filing confirms PMVC remains an empty shell actively searching for a target, with cash burn of approximately $10,000 per quarter and $1.1 million in cash. The lack of a trust means there is no redemption deadline or per-share trust value for investors to track. The sponsor continues to fund administrative expenses, and the warrants remain deeply out-of-the-money with a $503.61 strike price.

What changed: Form 10-K Annual Report for PMV Consumer Acquisition Corp. No new business combination announced. 2024 net loss of $156,380 vs 2023 net loss of $108,141. The company still searching. No new deal disclosed. Why it matters: Trust was redeemed in 2022; there is no trust value to track. Management is still searching; the cash burn rate suggests a limited runway. The warrants are still accounted for as liabilities but the fair value change was $0 in 2024 vs a $146,020 gain in 2023. Net loss per share increased to $1.56 from $1.08. Auditor issued clean opinion.

What changed: 10-Q (Quarterly Report) for PMV Consumer Acquisition Corp. (PMVC), a SPAC in searching status. No material change. PMVC remains a shell company with no business combination, no trust, and no pending deal. Net loss for the quarter was $45,555, cash was $1,130,295, and the trust was terminated in 2022. The only structural change was the charter amendment on April 30, 2024, reducing authorized shares. Why it matters: The filing confirms PMVC is still searching with no imminent deal. Trust is gone, so there is no redemption backstop for public shareholders. The sponsor controls the board and there are no extensions or deadlines remaining. The stock is essentially a option on sponsor's ability to find a deal, with no cash value floor.

What changed: Quarterly report on Form 10-Q for the period ended June 30, 2024. No change in trust value, no new redemption deadlines, no extension, no deal announcement, no suit, no resignation. Net loss of $28,356 for the quarter and $105,739 for the six months. Cash and cash equivalents increased slightly to $1,132,400 (from $1,072,630 at Dec. 31, 2023). Accumulated deficit widened to $(517,546) from $(411,807). The trust has been fully redeemed since December 27, 2022 and thus no mechanism for a redemption deadline remains. The company continues to search but has no transaction closed or announced. Why it matters: Updates current cash position and burn rate. The increase in related-party payables ($452,000 vs. $392,000) and the steady cash consumption signal that a business combination must occur before funds run out, though there is no stated deadline. The reverse stock split and warrant re-pricing (now $503.61/share) have eliminated the practical ability to exercise the warrants. The company remains a shell with no operations. No subsequent events identified.

What changed: Quarterly report (Form 10-Q) for the quarter ended March 31, 2024. No trust account remains (fully redeemed in December 2022). Reverse stock split effective March 12, 2024, reducing outstanding shares to 100,000. Authorized shares reduced in April 2024. Company continues to search for a business combination with no deal announced. Cash and cash equivalents $1.17 million. Why it matters: Confirms zero trust value and reliance on cash for operations. Reverse stock split and authorized share reduction suggest preparation for a potential transaction, but no progress on a deal. Sponsor retains control via Class B super-voting shares. Warrants are deeply out of the money ($503.61 exercise price), effectively worthless.

What changed: A Form 8-K current report containing a Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation. Per the registrant's filing, the Board of Directors recommended and the sole shareholder approved a reduction in authorized capital effective April 30, 2024. Total authorized shares drop from 55,000,000 to 1,260,000. Class A Common Stock decreases from 25,000,000 to 570,000; Class B Common Stock from 10,000,000 to 230,000; and Preferred Stock from 20,000,000 to 460,000. Each class retains a par value of $.0001, as executed by Co-Chief Executive Officer Robert V. LaPenta, Jr. This mechanical adjustment trims the charter's issuance ceiling but leaves all outstanding share counts, redemption windows, trust distribution formulas, extension provisions, and merger timelines completely unaltered. Why it matters: The authorization cut typically serves as administrative preparation to match a smaller post-business combination capital structure, though the Board attributed no broader strategic reason beyond acting in the Company’s best interest. The filing reiterates the warrant designation as 'Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $503.61 per share,' with ticker symbols PMVC and PMVC WS listed as 'N/A,' pointing to suspended or inactive trading status. Attributed exclusively to the company's Exhibit 3.1 and cover metadata, the document contains zero assertions regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or executive personnel. Consequently, it adds no new terms to the redemption calendar or trust mechanics, but clarifies the structural maximums for future equity issuance while the sponsor continues its search.

What changed: Form 10-K annual report for PMV Consumer Acquisition Corp., a blank check company (shell) still searching for a business combination. The trust account was fully redeemed as of December 31, 2022; no trust assets remain. For the year ended December 31, 2023, the company reported a net loss of $108,141 (vs. net income of $8,622,353 in 2022), driven by a $146,020 fair value adjustment on warrant liabilities and $51,915 interest income offset by $256,691 in G&A and $36,185 in taxes. Cash and cash equivalents decreased to $1,072,630 from $1,149,157. The company effected a reverse stock split (43.792-to-1) and reclassified Class C common stock to Class A common stock, effective March 12, 2024. Sponsor purchased 204,200 shares of Class C common stock in February 2023 and converted its Class A shares into Class C shares in November 2023. No business combination was completed; the extension deadline (September 21, 2023) passed with no deal. Why it matters: The SPAC's trust has been fully liquidated, eliminating any redemption deadline or per-share trust value for public shareholders. The company continues to search for a business opportunity with only working capital ($1.07M) and no possibility of public redemptions. The reverse stock split and capital restructuring have altered the share count and warrant terms (exercise price now $503.61). The warrants are deeply out of the money and may expire worthless. Sponsor actions (purchasing shares, converting) indicate continued commitment but the lack of a deal and minimal cash raise questions about future viability. The filing confirms the SPAC is in a holding pattern with no imminent transaction.

What changed: Quarterly report (Form 10-Q) for the period ended September 30, 2023. The trust account was fully liquidated in 2022 and no funds remain; the company has $1.1M cash. The initial business combination deadline (Sept 21, 2023) has passed without a deal. Subsequent events after the quarter end: the Sponsor converted all Class A shares to Class C, a 43.792-to-1 reverse stock split of Class B and C was approved, charter was amended to eliminate Class A and create new Class A (formerly Class C), and the bylaws were amended to permit stockholder action by written consent. These changes suggest the company is restructuring to pursue a business combination without a trust or public redemption rights. Why it matters: The SPAC is effectively restarting with a new capital structure, having liquidated its trust and eliminated public shares. The reverse split and charter amendments are preparatory steps for a potential business combination, possibly with a target that requires a simpler equity structure. Investors should monitor for a definitive agreement.

What changed: A Form 8-K current report disclosing the adoption of a Second Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws, following shareholder approval of corporate restructuring amendments and a reverse stock split. On November 2, 2023, the Company filed updated governing documents after the Board of Directors recommended and the sole Shareholder approved various amendments to the Charter and a 43.792-to-1 reverse stock split of all outstanding Class B and Class C Common Stock. Following the split, approximately 26,832 Class B shares and approximately 73,169 Class C shares will remain issued and outstanding. The amendments eliminate authorized shares of Class A Common Stock, rename Class C Common Stock to Class A Common Stock, eliminate Special Common Stock, delete provisions permitting Class B conversion into Class C, grant each record holder of Class B Common Stock ten (10) votes per share, delete certain Article SIXTH provisions referencing a business combination and/or the IPO Trust Account, and remove the requirement for the Board to be divided into staggered classes. A bylaw amendment now permits stockholder action by written consent in lieu of a meeting. Consistent with the Warrant Agreement, the 8,750,000 public warrants will be exercisable into approximately 199,808 shares and the 6,150,000 private placement warrants into approximately 140,437 shares, each at an exercise price of approximately $503.61 per share. Why it matters: The explicit deletion of provisions referencing the business combination and the IPO Trust Account signals that the SPAC’s original acquisition mandate and associated trust protections have been contractually extinguished, fundamentally altering shareholder recourse and eliminating standard redemption pathways tied to a completed deal. The extreme 43.792-to-1 reverse split and the resultant warrant exercise price increase to approximately $503.61 confirm a deep structural overhaul typical of a dormant shell repurposing or wind-down rather than active transaction pursuit. No new redemption calendar, trust distribution mechanism, or extension deadline is established. The restructured capitalization and concentrated voting rights for Class B holders consolidate control within the sponsor, while Co-President Timothy J. Foufas signed the filing, underscoring sponsor-driven execution of these governance shifts without announcing a target or seeking new capital raising initiatives beyond a general future possibility.

What changed: Form 10-Q quarterly report. The company continued its search for a business combination, reporting a net loss of $41,435 for the quarter and $140,025 for the six months ended June 30, 2023. The trust account was fully liquidated in December 2022, so no trust value is reported. Cash and cash equivalents decreased to $1.09 million from $1.15 million at year-end 2022. The company has until September 21, 2023 to complete a business combination under the extension granted in September 2022. Why it matters: PMVC is a post-redemption SPAC with no trust account, relying solely on its cash on hand ($1.09M) to fund operations and find a target. The clock on its extension runs out September 21, 2023. The company is burning cash at a modest rate but has no identified acquisition target. Warrants (8.75M public + 6.15M private) are classified as derivative liabilities and may expire worthless if no deal is completed.